Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
653 APN401, a novel EPiC-based anti-cancer cell therapy, case report: Cbl-b silenced, autologous PBMCs induced stable disease in an appendix carcinoma patient
Compose a Response to This Article
Other responses
No responses have been published for this article.